New society guidance: which patients are likely to benefit from renal denervation?

Back

Open Access

New society guidance: which patients are likely to benefit from renal denervation?

Session: Reducing cardiovascular events in hypertensive patients: new treatment options

Topic: Renal Denervation

Speaker: Professor R. Schmieder (Erlangen, DE)

About the speaker

Professor Roland Schmieder

University Hospital Erlangen, Erlangen (Germany)

25 presentations

0 follower

5 more presentations in this session

Introduction.

Speaker: Professor M. Boehm (Homburg, DE)

Access

Slides

Video

Can renal denervation reduce cardiovasculer events?

Speaker: Professor F. Mahfoud (Homburg, DE)

Access

Slides

Video

Cased-based discussion: patients intolerant to medications.

Speaker: Professor S. Brouwers (Aalst, BE)

Access

Slides

Video

Cased-based discussion: high CV risk patients.

Speaker: Doctor O. Rodriguez Leor (Barcelona, ES)

Access

Slides

Video

Discussion.

Speaker: Professor A. Pathak (Monaco, MC)

Access

Slides

Video

Access the full session

Reducing cardiovascular events in hypertensive patients: new treatment options

Speakers: Professor R. Schmieder, Professor M. Boehm, Professor F. Mahfoud, Professor S. Brouwers, Doctor O. Rodriguez Leor...

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

New society guidance: which patients are likely to benefit from renal denervation?

About the speaker

Professor Roland Schmieder

5 more presentations in this session

Introduction.

Can renal denervation reduce cardiovasculer events?

Cased-based discussion: patients intolerant to medications.

Cased-based discussion: high CV risk patients.

Discussion.

Access the full session

Reducing cardiovascular events in hypertensive patients: new treatment options

About the event

ESC Congress 2022

ESC 365 is supported by